Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GlyT-1 Inhibitor for Refractory Schizophrenia
NCT01251055Phase 2Completed
- Sponsor
- China Medical University Hospital
- Start
- Apr 2010
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in schizophrenia comparing Sarcosine + Clozapine with Placebo + Clozapine (2 arms). Primary endpoint: The severity of psychiatric symptoms at 6 weeks. Started Apr 2010; status: completed.
02
Drugs
sarcosine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT01251055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01251055.